Moderna’s new CMO Paul Burton spoke to reporters Thursday morning, attempting to defend his company’s vaccine against questions around heart-related risks that appear to be cropping...
Check these penny stocks out for your watchlist in November The post Are These Penny Stocks Worth Being Bullish On? 3 to Watch appeared first on...
Pfizer Inc (NYSE: PFE) is seeking authorisation from the U.S. FDA for COVID-19 vaccine boosters for all adults to fortify waning immunity in Americans ahead of...
Tackling antimicrobial resistance (AMR) requires a one health approach that joins the dots between the human, animal, and The post One world, one health: The interconnected...
The US federal government has ordered another 1.4 million doses of Merck & Co and Ridgeback Biotherapeutics’ oral The post US buys another $1 billion-worth of...
Pfizer Inc. and BioNTech SE on November 9 requested the U.S. Food and Drug Administration to authorize booster doses of their Covid-19 vaccine in all adults,...
Bloomberg reports this week that the VIX (the CBOE Volatility Index) is rallying with the S&P 500 in a rare way over the past few weeks....
The popularity of decentralized clinical trials (DCTs) is surging, especially among patients. Harnessing technology of all kinds, these trials provide an attractive alternative to the old-style,...
Regeneron Pharmaceuticals Inc (NASDAQ: REGN) on Monday said a single dose of REGEN-COV triggers long-term immunity against COVID-19. Shares of the biotech company were up more...
Which biotech penny stocks are you watching this month? The post Best Biotech Penny Stocks to Buy in November? 3 to Watch Now appeared first on...
Pfizer Inc. (NYSE: PFE) stock jumped 10% last week after the company announced results for its COVID-19 oral antiviral pill that indicated the tablet was 89%...
Parents Increasingly Worried About Being Forced To Vaccinate Young Children As Biden Tightens Mandates Anybody who has been paying attention to the Biden Administration's increasingly coercive...
Pfizer plans to seek Emergency Use Authorization (EUA) for an antiviral Covid-19 treatment following an interim analysis of Phase II/III data shown to be statistically and...
The U.S. government canceled a contract with Maryland-based Emergent BioSolutions, which ruined about 15 million doses of the Johnson & Johnson vaccine earlier in the year.
An infectious diseases doctor reviews the evidence, discusses hesitancy and concerns about side-effects and explains the overwhelming case for vaccinating five-to-11-year-olds, including his own son.
Pfizer Inc (NYSE: PFE) reported data for its oral COVID-19 antiviral on Friday that showed the pill to be 89% effective in reducing hospitalisation and death....
Pfizer Shares Surge After Release Of 'Miracle' COVID Pill That Is 89% Effective At Preventing Hospitalization Thursday was a rough day for Moderna shares after the...
Dietary supplement companies with health-focused and plant-based ingredients, including omega-3 fatty acids, will likely present an exciting opportunity for investors seeking to capitalize on the market’s...
Pfizer Vax Trial Being Probed After Whistleblower Exposes 'Falsified Data', According To Contractor Authored by Zachary Stieber via The Epoch Times (emphasis ours), The alleged problems...
"They Put Their Life At Risk": Sen. Paul Decries Firing Of Frontline Workers Over Vaccine Mandates Authored by Zachary Stieber via The Epoch Times, Firefighters, nurses,...
The US unemployment claims report is expected this week, cotton price continues to rise, children are getting COVID-19 vaccine, and equities show mixed sentiment. Jobless claims...
The Pfizer share price gained over 4% yesterday after the company behind one of… The post Pfizer share price gains 4% on expectations for $65 billion...
A real-world study of digital therapeutic (DTx) for opioid use disorder has found that patient show used it The post Digital therapeutic cuts opioid use disorder...
Shortly after the U.S. FDA authorised Pfizer Inc’s (NYSE: PFE) COVID-19 vaccine for children as young as five years old, the CDC has followed in its...
Dividend stocks could be worth paying attention to as the Federal Reserve may look to pull back its monetary support. The post Best Stocks To Buy...
The US is now pressing ahead with plans to extend its COVID-19 vaccination campaign to younger children aged The post US backs COVID jabs for young...
Advisers to the U.S. Centers for Disease Control and Prevention (CDC) on Nov. 2 unanimously supported broad use of Pfizer and BioNTech's Covid-19 vaccine in children...
'Falsified Data': Pfizer Vaccine Trial Had Major Flaws, Whistleblower Tells Peer-Reviewed Journal A whistleblower involved in Pfizer's pivotal phase III Covid-19 vaccine trial has leaked evidence...
Pfizer Inc. on Nov. 2 said the company expected 2021 sales of the Covid-19 vaccine developed with German partner BioNTech SE would reach $36 billion and...
Novavax has been granted its first emergency use authorisation in Indonesia for COVID-19 vaccine NVX-CoV2373, and expects other The post Novavax gets first authorisation for its...